SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-591982
Filing Date
2016-05-16
Accepted
2016-05-16 16:46:57
Documents
43
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d179788d10q.htm 10-Q 252602
2 EX-31.1 d179788dex311.htm EX-31.1 8126
3 EX-31.2 d179788dex312.htm EX-31.2 8132
4 EX-32.1 d179788dex321.htm EX-32.1 4265
5 EX-32.2 d179788dex322.htm EX-32.2 4271
  Complete submission text file 0001193125-16-591982.txt   1637077

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT wve-20160331.xml EX-101.INS 174297
7 XBRL TAXONOMY EXTENSION SCHEMA wve-20160331.xsd EX-101.SCH 22877
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wve-20160331_cal.xml EX-101.CAL 38858
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wve-20160331_def.xml EX-101.DEF 91937
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20160331_lab.xml EX-101.LAB 216595
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20160331_pre.xml EX-101.PRE 145078
Mailing Address 8 CROSS STREET #10-00 SINGAPORE U0 048424
Business Address 8 CROSS STREET #10-00 SINGAPORE U0 048424 617-206-4830
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37627 | Film No.: 161654647
SIC: 2834 Pharmaceutical Preparations